United States Active Pharma Ingredient Market Report 2016

October 2016 | 105 pages | ID: U8A5AF1C62EEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Active Pharma Ingredient

Revenue, means the sales value of Active Pharma Ingredient

This report studies sales (consumption) of Active Pharma Ingredient in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Teva
• DSM
• Novartis
• Johnson?&?Johnson
• Dr. Reddy’s
• Pfizer
• Bayer
• BASF
• Cambrex
• Sun Pharmaceutical
• Lonza group
• Boehringer Ingelheim
• Aurobindo pharma
• Lupin
• Biocon
• Cipla
• Haerbin Pharmaceutical
• North East Pharmaceutical

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Vitamin
• Antibiotic
• Antipyretic and Analgesic Activities
• Hormone
• Amino Acid
• Cardiovascular

Split by applications, this report focuses on sales, market share and growth rate of Active Pharma Ingredient in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Active Pharma Ingredient Market Report 2016

1 ACTIVE PHARMA INGREDIENT OVERVIEW

1.1 Product Overview and Scope of Active Pharma Ingredient
1.2 Classification of Active Pharma Ingredient
  1.2.1 Vitamin
  1.2.2 Antibiotic
  1.2.3 Antipyretic and Analgesic Activities
  1.2.4 Hormone
  1.2.5 Amino Acid
  1.2.6 Cardiovascular
1.3 Application of Active Pharma Ingredient
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Active Pharma Ingredient (2011-2021)
  1.4.1 United States Active Pharma Ingredient Sales and Growth Rate (2011-2021)
  1.4.2 United States Active Pharma Ingredient Revenue and Growth Rate (2011-2021)

2 UNITED STATES ACTIVE PHARMA INGREDIENT COMPETITION BY MANUFACTURERS

2.1 United States Active Pharma Ingredient Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Active Pharma Ingredient Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Active Pharma Ingredient Average Price by Manufactures (2015 and 2016)
2.4 Active Pharma Ingredient Market Competitive Situation and Trends
  2.4.1 Active Pharma Ingredient Market Concentration Rate
  2.4.2 Active Pharma Ingredient Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ACTIVE PHARMA INGREDIENT SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Active Pharma Ingredient Sales and Market Share by Type (2011-2016)
3.2 United States Active Pharma Ingredient Revenue and Market Share by Type (2011-2016)
3.3 United States Active Pharma Ingredient Price by Type (2011-2016)
3.4 United States Active Pharma Ingredient Sales Growth Rate by Type (2011-2016)

4 UNITED STATES ACTIVE PHARMA INGREDIENT SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Active Pharma Ingredient Sales and Market Share by Application (2011-2016)
4.2 United States Active Pharma Ingredient Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES ACTIVE PHARMA INGREDIENT MANUFACTURERS PROFILES/ANALYSIS

5.1 Teva
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Active Pharma Ingredient Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Teva Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 DSM
  5.2.2 Active Pharma Ingredient Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 DSM Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Novartis
  5.3.2 Active Pharma Ingredient Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Novartis Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Johnson?&?Johnson
  5.4.2 Active Pharma Ingredient Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Johnson?&?Johnson Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Dr. Reddy’s
  5.5.2 Active Pharma Ingredient Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Dr. Reddy’s Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Pfizer
  5.6.2 Active Pharma Ingredient Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Pfizer Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Bayer
  5.7.2 Active Pharma Ingredient Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Bayer Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 BASF
  5.8.2 Active Pharma Ingredient Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 BASF Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Cambrex
  5.9.2 Active Pharma Ingredient Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Cambrex Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Sun Pharmaceutical
  5.10.2 Active Pharma Ingredient Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Sun Pharmaceutical Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Lonza group
5.12 Boehringer Ingelheim
5.13 Aurobindo pharma
5.14 Lupin
5.15 Biocon
5.16 Cipla
5.17 Haerbin Pharmaceutical
5.18 North East Pharmaceutical

6 ACTIVE PHARMA INGREDIENT MANUFACTURING COST ANALYSIS

6.1 Active Pharma Ingredient Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Active Pharma Ingredient

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Active Pharma Ingredient Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Active Pharma Ingredient Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES ACTIVE PHARMA INGREDIENT MARKET FORECAST (2016-2021)

10.1 United States Active Pharma Ingredient Sales, Revenue Forecast (2016-2021)
10.2 United States Active Pharma Ingredient Sales Forecast by Type (2016-2021)
10.3 United States Active Pharma Ingredient Sales Forecast by Application (2016-2021)
10.4 Active Pharma Ingredient Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Active Pharma Ingredient
Table Classification of Active Pharma Ingredient
Figure United States Sales Market Share of Active Pharma Ingredient by Type in 2015
Figure Vitamin Picture
Figure Antibiotic Picture
Figure Antipyretic and Analgesic Activities Picture
Figure Hormone Picture
Figure Amino Acid Picture
Figure Cardiovascular Picture
Table Application of Active Pharma Ingredient
Figure United States Sales Market Share of Active Pharma Ingredient by Application in 2015
Figure United States Active Pharma Ingredient Sales and Growth Rate (2011-2021)
Figure United States Active Pharma Ingredient Revenue and Growth Rate (2011-2021)
Table United States Active Pharma Ingredient Sales of Key Manufacturers (2015 and 2016)
Table United States Active Pharma Ingredient Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Active Pharma Ingredient Sales Share by Manufacturers
Figure 2016 Active Pharma Ingredient Sales Share by Manufacturers
Table United States Active Pharma Ingredient Revenue by Manufacturers (2015 and 2016)
Table United States Active Pharma Ingredient Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Active Pharma Ingredient Revenue Share by Manufacturers
Table 2016 United States Active Pharma Ingredient Revenue Share by Manufacturers
Table United States Market Active Pharma Ingredient Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Active Pharma Ingredient Average Price of Key Manufacturers in 2015
Figure Active Pharma Ingredient Market Share of Top 3 Manufacturers
Figure Active Pharma Ingredient Market Share of Top 5 Manufacturers
Table United States Active Pharma Ingredient Sales by Type (2011-2016)
Table United States Active Pharma Ingredient Sales Share by Type (2011-2016)
Figure United States Active Pharma Ingredient Sales Market Share by Type in 2015
Table United States Active Pharma Ingredient Revenue and Market Share by Type (2011-2016)
Table United States Active Pharma Ingredient Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Active Pharma Ingredient by Type (2011-2016)
Table United States Active Pharma Ingredient Price by Type (2011-2016)
Figure United States Active Pharma Ingredient Sales Growth Rate by Type (2011-2016)
Table United States Active Pharma Ingredient Sales by Application (2011-2016)
Table United States Active Pharma Ingredient Sales Market Share by Application (2011-2016)
Figure United States Active Pharma Ingredient Sales Market Share by Application in 2015
Table United States Active Pharma Ingredient Sales Growth Rate by Application (2011-2016)
Figure United States Active Pharma Ingredient Sales Growth Rate by Application (2011-2016)
Table Teva Basic Information List
Table Teva Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Teva Active Pharma Ingredient Sales Market Share (2011-2016)
Table DSM Basic Information List
Table DSM Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Table DSM Active Pharma Ingredient Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Active Pharma Ingredient Sales Market Share (2011-2016)
Table Johnson?&?Johnson Basic Information List
Table Johnson?&?Johnson Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson?&?Johnson Active Pharma Ingredient Sales Market Share (2011-2016)
Table Dr. Reddy’s Basic Information List
Table Dr. Reddy’s Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dr. Reddy’s Active Pharma Ingredient Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Active Pharma Ingredient Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Active Pharma Ingredient Sales Market Share (2011-2016)
Table BASF Basic Information List
Table BASF Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Table BASF Active Pharma Ingredient Sales Market Share (2011-2016)
Table Cambrex Basic Information List
Table Cambrex Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cambrex Active Pharma Ingredient Sales Market Share (2011-2016)
Table Sun Pharmaceutical Basic Information List
Table Sun Pharmaceutical Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sun Pharmaceutical Active Pharma Ingredient Sales Market Share (2011-2016)
Table Lonza group Basic Information List
Table Lonza group Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lonza group Active Pharma Ingredient Sales Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim Active Pharma Ingredient Sales Market Share (2011-2016)
Table Aurobindo pharma Basic Information List
Table Aurobindo pharma Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aurobindo pharma Active Pharma Ingredient Sales Market Share (2011-2016)
Table Lupin Basic Information List
Table Lupin Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lupin Active Pharma Ingredient Sales Market Share (2011-2016)
Table Biocon Basic Information List
Table Biocon Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biocon Active Pharma Ingredient Sales Market Share (2011-2016)
Table Cipla Basic Information List
Table Cipla Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cipla Active Pharma Ingredient Sales Market Share (2011-2016)
Table Haerbin Pharmaceutical Basic Information List
Table Haerbin Pharmaceutical Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Table Haerbin Pharmaceutical Active Pharma Ingredient Sales Market Share (2011-2016)
Table North East Pharmaceutical Basic Information List
Table North East Pharmaceutical Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Table North East Pharmaceutical Active Pharma Ingredient Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Active Pharma Ingredient
Figure Manufacturing Process Analysis of Active Pharma Ingredient
Figure Active Pharma Ingredient Industrial Chain Analysis
Table Raw Materials Sources of Active Pharma Ingredient Major Manufacturers in 2015
Table Major Buyers of Active Pharma Ingredient
Table Distributors/Traders List
Figure United States Active Pharma Ingredient Production and Growth Rate Forecast (2016-2021)
Figure United States Active Pharma Ingredient Revenue and Growth Rate Forecast (2016-2021)
Table United States Active Pharma Ingredient Production Forecast by Type (2016-2021)
Table United States Active Pharma Ingredient Consumption Forecast by Application (2016-2021)